InsidersTradesSigma
Browse the full record of transactions filed by Sofia Heigis, Chief Executive Officer. Director active across 2 companies, notably Oncopeptides AB. In total, 1 filings have been published. The latest transaction was disclosed on 17 March 2026 (Purchase). Regulator: FIN-FSA. All data is free.
1 of 1 declaration
Sofia Heigis is the CEO of Oncopeptides AB. She is responsible for the strategic and operational direction of the company, ensuring its development and performance in the market.